Correlation Between Molecular Templates and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and ProMIS Neurosciences, you can compare the effects of market volatilities on Molecular Templates and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and ProMIS Neurosciences.
Diversification Opportunities for Molecular Templates and ProMIS Neurosciences
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Molecular and ProMIS is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Molecular Templates i.e., Molecular Templates and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Molecular Templates and ProMIS Neurosciences
Given the investment horizon of 90 days Molecular Templates is expected to generate 3.57 times more return on investment than ProMIS Neurosciences. However, Molecular Templates is 3.57 times more volatile than ProMIS Neurosciences. It trades about 0.01 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.08 per unit of risk. If you would invest 50.00 in Molecular Templates on August 29, 2024 and sell it today you would lose (13.00) from holding Molecular Templates or give up 26.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Templates vs. ProMIS Neurosciences
Performance |
| Timeline |
| Molecular Templates |
| ProMIS Neurosciences |
Molecular Templates and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and ProMIS Neurosciences
The main advantage of trading using opposite Molecular Templates and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| Molecular Templates vs. Eliem Therapeutics | Molecular Templates vs. Scpharmaceuticals | Molecular Templates vs. Milestone Pharmaceuticals | Molecular Templates vs. Seres Therapeutics |
| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |